1 01/11/2022 31/10/2023 2023-10-31 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2022-11-01 Sage Accounts Production 23.0 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 10414554 2022-11-01 2023-10-31 10414554 2023-10-31 10414554 2022-10-31 10414554 2021-11-01 2022-10-31 10414554 2022-10-31 10414554 2021-10-31 10414554 core:FurnitureFittingsToolsEquipment 2022-11-01 2023-10-31 10414554 bus:RegisteredOffice 2022-11-01 2023-10-31 10414554 bus:LeadAgentIfApplicable 2022-11-01 2023-10-31 10414554 bus:Agent1 2022-11-01 2023-10-31 10414554 bus:Director1 2022-11-01 2023-10-31 10414554 core:FurnitureFittingsToolsEquipment 2022-10-31 10414554 core:FurnitureFittingsToolsEquipment 2023-10-31 10414554 core:RetainedEarningsAccumulatedLosses 2021-11-01 2022-10-31 10414554 core:RetainedEarningsAccumulatedLosses 2022-11-01 2023-10-31 10414554 core:WithinOneYear 2023-10-31 10414554 core:WithinOneYear 2022-10-31 10414554 bus:AllOrdinaryShares 2022-11-01 2023-10-31 10414554 bus:AllOrdinaryShares 2021-11-01 2022-10-31 10414554 core:ShareCapital 2023-10-31 10414554 core:ShareCapital 2022-10-31 10414554 core:RetainedEarningsAccumulatedLosses 2023-10-31 10414554 core:RetainedEarningsAccumulatedLosses 2022-10-31 10414554 core:ShareCapital 2021-10-31 10414554 core:RetainedEarningsAccumulatedLosses 2021-10-31 10414554 core:PreviouslyStatedAmount core:ShareCapital 2023-10-31 10414554 bus:OrdinaryShareClass1 core:ShareCapital 2022-10-31 10414554 core:FurnitureFittingsToolsEquipment 2022-10-31 10414554 bus:Director1 2022-10-31 10414554 bus:Director1 2023-10-31 10414554 bus:Director1 2021-10-31 10414554 bus:Director1 2022-10-31 10414554 bus:Director1 2021-11-01 2022-10-31 10414554 bus:SmallEntities 2022-11-01 2023-10-31 10414554 bus:AuditExemptWithAccountantsReport 2022-11-01 2023-10-31 10414554 bus:SmallCompaniesRegimeForAccounts 2022-11-01 2023-10-31 10414554 bus:PrivateLimitedCompanyLtd 2022-11-01 2023-10-31 10414554 bus:FullAccounts 2022-11-01 2023-10-31 10414554 bus:OrdinaryShareClass1 2022-11-01 2023-10-31
Company registration number: 10414554
DIGITAL HEALTH GROUP LTD
Unaudited filleted financial statements
31 October 2023
DIGITAL HEALTH GROUP LTD
Contents
Directors and other information
Director's report
Accountants report
Statement of financial position
Statement of changes in equity
Notes to the financial statements
DIGITAL HEALTH GROUP LTD
Directors and other information
Director Mr Asmat Ullah
Company number 10414554
Registered office Solar House
915 High Road
London
N12 8QJ
Business address Solar House
915 High Road
London
N12 8QJ
Accountants STERLING WISE
Chartered Certified Accountants
85 Lynton Avenue
London
NW9 6PB
Bankers Barclays Bank Plc
Monzo Bank
DIGITAL HEALTH GROUP LTD
Director's report
Year ended 31 October 2023
The director presents his report and the unaudited financial statements of the company for the year ended 31 October 2023.
Director
The director who served the company during the year was as follows:
Mr Asmat Ullah
Dividends
Particulars of recommended dividends are detailed in note 6 to the unaudited financial statements.
Director's responsibilities statement
The director is responsible for preparing the director's report and the financial statements in accordance with applicable law and regulations.
Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the director must not approve the financial statements unless he is satisfied that they give a true and fair view of the state of affairs of the company and the profit or loss of the company for that period.
In preparing these financial statements, the director is required to:
- select suitable accounting policies and then apply them consistently;
- make judgments and accounting estimates that are reasonable and prudent; and
- state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable him to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The director is responsible for the maintenance and integrity of the corporate and financial information included on the company's website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.
Small company provisions
This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.
This report was approved by the board of directors on 03 February 2024 and signed on behalf of the board by:
Mr Asmat Ullah
Director
DIGITAL HEALTH GROUP LTD
Report to the director on the preparation of the
unaudited statutory financial statements of DIGITAL HEALTH GROUP LTD
Year ended 31 October 2023
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of DIGITAL HEALTH GROUP LTD for the year ended 31 October 2023 which comprise the statement of financial position, statement of changes in equity and related notes from the company's accounting records and from information and explanations you have given us.
As a practising member firm of the Association of Chartered Certified Accountants , we are subject to its ethical and other professional requirements which are detailed at http://www.accaglobal.com/en/member/ professional-standards/ rules-standards/acca-rulebook.html.
This report is made solely to the director of DIGITAL HEALTH GROUP LTD, as a body, in accordance with the terms of our engagement letter dated 1 July 2018. Our work has been undertaken solely to prepare for your approval the financial statements of DIGITAL HEALTH GROUP LTD and state those matters that we have agreed to state to them, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at http://www.accaglobal.com/content/dam/ACCA_Global /Technical/fact/technical-factsheet-163.pdf. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than DIGITAL HEALTH GROUP LTD and its director as a body for our work or for this report.
It is your duty to ensure that DIGITAL HEALTH GROUP LTD has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of DIGITAL HEALTH GROUP LTD. You consider that DIGITAL HEALTH GROUP LTD is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the financial statements of DIGITAL HEALTH GROUP LTD. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
STERLING WISE
Chartered Certified Accountants
85 Lynton Avenue
London
NW9 6PB
3 February 2024
DIGITAL HEALTH GROUP LTD
Statement of financial position
31 October 2023
2023 2022
Note £ £ £ £
Fixed assets
Tangible assets 7 2,565 3,998
_______ _______
2,565 3,998
Current assets
Debtors 8 23,497 11,314
Cash at bank and in hand 551,767 731,293
_______ _______
575,264 742,607
Creditors: amounts falling due
within one year 9 ( 6,816) ( 161,823)
_______ _______
Net current assets 568,448 580,784
_______ _______
Total assets less current liabilities 571,013 584,782
_______ _______
Net assets 571,013 584,782
_______ _______
Capital and reserves
Called up share capital 10 100 100
Profit and loss account 570,913 584,682
_______ _______
Shareholder funds 571,013 584,782
_______ _______
For the year ending 31 October 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
- The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
These financial statements were approved by the board of directors and authorised for issue on 03 February 2024 , and are signed on behalf of the board by:
Mr Asmat Ullah
Director
Company registration number: 10414554
DIGITAL HEALTH GROUP LTD
Statement of changes in equity
Year ended 31 October 2023
Called up share capital Profit and loss account Total
£ £ £
At 1 November 2021 100 28 128
Profit for the year 622,654 622,654
_______ _______ _______
Total comprehensive income for the year - 622,654 622,654
Dividends paid and payable ( 38,000) ( 38,000)
_______ _______ _______
Total investments by and distributions to owners - ( 38,000) ( 38,000)
_______ _______ _______
At 31 October 2022 and 1 November 2022 100 584,682 584,782
Profit for the year 15,501 15,501
_______ _______ _______
Total comprehensive income for the year - 15,501 15,501
Dividends paid and payable ( 29,270) ( 29,270)
_______ _______ _______
Total investments by and distributions to owners - ( 29,270) ( 29,270)
_______ _______ _______
At 31 October 2023 100 570,913 571,013
_______ _______ _______
DIGITAL HEALTH GROUP LTD
Notes to the financial statements
Year ended 31 October 2023
1. General information
The company is a private company limited by shares, registered in England. The address of the registered office is Solar House, 915 High Road, London, N12 8QJ.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
The Financial Statements have been prepared on going concern basis.
Turnover
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Operating leases
Lease payments are recognised as an expense over the lease term on a straight-line basis. The aggregate benefit of lease incentives is recognised as a reduction to expense over the lease term, on a straight-line basis.
Research and development
Research expenditure is written off in the year in which it is incurred. Development expenditure incurred is capitalised as an intangible asset only when all of the following criteria are met: - It is technically feasible to complete the intangible asset so that it will be available for use or sale; - There is the intention to complete the intangible asset and use or sell it; - There is the ability to use or sell the intangible asset; - The use or sale of the intangible asset will generate probable future economic benefits; - There are adequate technical, financial and other resources available to complete the development and to use or sell the intangible asset; and - The expenditure attributable to the intangible asset during its development can be measured reliably. Expenditure that does not meet the above criteria is expensed as incurred.
Tangible assets
tangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in capital and reserves, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Fittings fixtures and equipment - 33.33 % reducing balance
If there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates.
Impairment
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.
4. Staff costs
The average number of persons employed by the company during the year amounted to 1 (2022: 1 ).
The aggregate payroll costs incurred during the year were:
2023 2022
£ £
Wages and salaries 21,000 3,500
Social security costs 1,426 -
_______ _______
22,426 3,500
_______ _______
5. Directors remuneration
The director's aggregate remuneration in respect of qualifying services was:
2023 2022
£ £
Remuneration 21,000 3,500
_______ _______
6. Dividends
Equity dividends
2023 2022
£ £
Dividends paid during the year (excluding those for which a liability existed at the end of the prior year) 29,270 38,000
_______ _______
7. Tangible assets
Fixtures, fittings and equipment Total
£ £
Cost
At 1 November 2022 and 31 October 2023 6,467 6,467
_______ _______
Depreciation
At 1 November 2022 2,469 2,469
Charge for the year 1,433 1,433
_______ _______
At 31 October 2023 3,902 3,902
_______ _______
Carrying amount
At 31 October 2023 2,565 2,565
_______ _______
At 31 October 2022 3,998 3,998
_______ _______
8. Debtors
2023 2022
£ £
Trade debtors 5,926 -
Other debtors 17,571 11,314
_______ _______
23,497 11,314
_______ _______
9. Creditors: amounts falling due within one year
2023 2022
£ £
Corporation tax 3,972 145,352
Social security and other taxes 344 -
Other creditors 2,500 16,471
_______ _______
6,816 161,823
_______ _______
10. Called up share capital
Issued, called up and fully paid
2023 2022
No £ No £
100 shares of £ 1- each (2022: £1.00 ) 100 100 100 100
_______ _______ _______ _______
100 100 100 100
_______ _______ _______ _______
11. Directors advances, credits and guarantees
During the year the director entered into the following advances and credits with the company:
2023
Balance brought forward Advances /(credits) to the director Balance o/standing
£ £ £
Mr Asmat Ullah ( 12,471) 20,406 7,935
_______ _______ _______
2022
Balance brought forward Advances /(credits) to the director Balance o/standing
£ £ £
Mr Asmat Ullah ( 45,619) 33,148 ( 12,471)
_______ _______ _______